Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2018
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancerP Cottu, V D'Hondt, S Dureau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2016
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational studyS Delaloge, D Pérol, C Courtinard, et al.
ESMO Open|September 2, 2025
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trialT Pascual, G Villacampa, M Oliveira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent diseaseM K Wilson, E Pujade-Lauraine, D Aoki, et al.
Breast Cancer Research and Treatment|January 5, 2022
Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohortM Bringuier, M Carton, C Levy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2020
Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016Matthieu Frasca, Camille Sabathe, Suzette Delaloge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2025
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancerA Mamann, Y Pradat, F C Bidard, et al.
European Journal of Neurology|August 12, 2018
Prevalence and phenotype of the c.1529C>T SPG7 variant in adult-onset cerebellar ataxia in ItalyC Mancini, E Giorgio, A Rubegni, et al.
ESMO Open|April 25, 2021
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohortT Grinda, A Antoine, W Jacot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2025
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trialEva Ciruelos, Tomás Pascual, Guillermo Villacampa, et al.
Pageof 22